Showing results (41-50 of 61) with videos related to
Sort By:
Pageof 7
Nature Microbiology|November 28, 2018
Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humansKuan-Ying A Huang, Pramila Rijal, Haihai Jiang, et al.Mabs|August 18, 2020
A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapyXiaoniu Miao, Yi Luo, Xi Huang, et al.Plos Pathogens|February 26, 2021
Breadth and function of antibody response to acute SARS-CoV-2 infection in humansKuan-Ying A Huang, Tiong Kit Tan, Ting-Hua Chen, et al.Cell Host & Microbe|June 26, 2020
Neutralization of SARS-CoV-2 by Destruction of the Prefusion SpikeJiandong Huo, Yuguang Zhao, Jingshan Ren, et al.Communications Medicine|May 23, 2022
A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concernNina Urke Ertesvåg, Julie Xiao, Fan Zhou, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2021
Immune Responses to a Single Dose of the AZD1222/Covishield Vaccine at 16 Weeks in Individuals in Sri LankaChandima Jeewandara, Dinuka Guruge, Pradeep Darshana Pushpakumara, et al.Plos Pathogens|December 10, 2021
Correction: Breadth and function of antibody response to acute SARS-CoV-2 infection in humansKuan-Ying A Huang, Tiong Kit Tan, Ting-Hua Chen, et al.Immunology|June 27, 2022
Immune responses to Sinopharm/BBIBP-CorV in individuals in Sri LankaChandima Jeewandara, Inoka Sepali Aberathna, Pradeep Darshana Pushpakumara, et al.Medrxiv : the Preprint Server for Health Sciences|October 27, 2021
Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individualsChandima Jeewandara, Inoka Sepali Aberathna, Pradeep Darshana Pushpakumara, et al.Cell Reports|April 4, 2019
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated HumansPramila Rijal, Sean C Elias, Samara Rosendo Machado, et al.Pageof 7